Kai LangelSenior Director, Strategy and Innovation, Global Regulatory Policy and Intelligence, Janssen R&D at Janssen R&D, Belgium
Kai Langel, Senior Director, Strategy and Innovation, Global Regulatory Policy and Intelligence, Janssen R&D
Since 2000, Kai has been a pioneer in patient-facing solutions for clinical trials working with young innovative technology companies. In 2012, Kai co-founded eClinicalHealth, the developers of the Clinpal remote clinical trial platform. Through his involvement in technical, operational and scientific roles, he has gained deep and holistic understanding of the clinical trial process and the key mechanisms of our ecosystem. Kai brings his entrepreneurial spirit and creative mindset to support Janssen’s global regulatory policy work across a range of topics. Kai has a passion for broad pre-competitive collaboration and is motivated to modernize the ways our broader ecosystem works together to advance the adoption of novel tools and methods to support efficient and patient-centric pharmaceutical R&D.
Digital Measurement Standards: What are They and How can They Enable the Scalable use of Digitally Derived Evidence?, 09:30View Session
PANEL: Biggest Learning - One Size Approach Doesn’t Fit All and Addressing Challenges and Future Prospects for DCT, 15:00View Session